Graham, Mark J.
Yale University,
United States
2025 Rank: 88,644
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Education
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1,119 out of 105,560 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 88,644 | 92,820 |
| Total Cites | 1,529 | 1,644 |
| H-index | 19 | 21 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 137 | 141 |
| Number of Single+First+Last Authored Papers | 35 | 35 |
| Total Cites to Single+First+Last Authored Papers | 238 | 244 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,256 | 1,322 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.24 |
| Self-Citation Percentage |
7.00%
|
|
Graham, Mark J.
Ionis Pharmaceuticals, Inc.,
United States
2024 Rank: 142,951
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 2,530 out of 208,384 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 142,951 | 146,261 |
| Total Cites | 1,141 | 1,255 |
| H-index | 18 | 20 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 102 | 107 |
| Number of Single+First+Last Authored Papers | 10 | 10 |
| Total Cites to Single+First+Last Authored Papers | 102 | 107 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 866 | 930 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.35 |
| Self-Citation Percentage |
9.08%
|
|
Graham, Mark J.
Ionis Pharmaceuticals, Inc.,
United States
2023 Rank: 119,863
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 2,370 out of 204,091 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 119,863 | 128,751 |
| Total Cites | 1,269 | 1,411 |
| H-index | 19 | 20 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 123 | 128 |
| Number of Single+First+Last Authored Papers | 10 | 10 |
| Total Cites to Single+First+Last Authored Papers | 123 | 128 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 927 | 996 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.42 |
| Self-Citation Percentage |
10.06%
|
|
Graham, Mark J.
Ionis Pharmaceuticals, Inc.,
United States
2022 Rank: 109,409
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 2,552 out of 201,173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 109,409 | 116,629 |
| Total Cites | 1,287 | 1,475 |
| H-index | 19 | 20 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 118 | 133 |
| Number of Single+First+Last Authored Papers | 10 | 10 |
| Total Cites to Single+First+Last Authored Papers | 119 | 134 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 943 | 1,026 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.44 |
| Self-Citation Percentage |
12.75%
|
|
Graham, Mark J.
Ionis Pharmaceuticals, Inc.,
United States
2021 Rank: 123,711
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 2,722 out of 189,264 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 123,711 | 122,854 |
| Total Cites | 1,834 | 2,107 |
| H-index | 22 | 24 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 184 | 201 |
| Number of Single+First+Last Authored Papers | 10 | 10 |
| Total Cites to Single+First+Last Authored Papers | 185 | 202 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,332 | 1,456 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.45 |
| Self-Citation Percentage |
12.96%
|
|
Graham, Mark J.
Ionis Pharmaceuticals, Inc.,
United States
2020 Rank: 115,630
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 2,233 out of 135,836 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 115,630 | 118,411 |
| Total Cites | 1,328 | 1,564 |
| H-index | 18 | 20 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 141 | 151 |
| Number of Single+First+Last Authored Papers | 10 | 10 |
| Total Cites to Single+First+Last Authored Papers | 143 | 153 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 961 | 1,071 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.46 |
| Self-Citation Percentage |
15.09%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.